Kyrixzon SB 1000mg/500mg Injection
Marketer
Felix Health Park
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Kyrixzon SB 1000mg/500mg Injection
Combiflox, a 1000mg/500mg injectable dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under medical guidance. Strict adherence to the prescribed dosage schedule is crucial; premature cessation may compromise treatment efficacy. Complete the full course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Optimal recovery necessitates adequate rest, a balanced diet, and sufficient hydration. Your physician may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Kyrixzon SB 1000mg/500mg Injection
No information provided. Unable to rephrase.
Uses of Kyrixzon SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Kyrixzon SB 1000mg/500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kyrixzon SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kyrixzon SB 1000mg/500mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kyrixzon SB 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Kyrixzon SB 1000mg/500mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a crucial antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Kyrixzon SB 1000mg/500mg Injection with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Kyrixzon SB (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data from human trials are currently scarce.
Breast feedingCAUTION
Administration of Kyrixzon SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Kyrixzon SB 1000mg/500mg Injection may induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kyrixzon SB 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Kyrixzon SB 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician before use. Dosage alteration for Kyrixzon SB 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kyrixzon SB 1000mg/500mg Injection :
Omit a Kyrixzon SB 1000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Kyrixzon SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently